Slow enrollment is the single biggest operational bottleneck in clinical research. About 80% of trials miss their enrollment timelines, 37% of trial sites under-enroll, and 11% enroll no patients at all. Each day of delay costs roughly $40,000 in direct trial expenses and approximately $500,000 in lost future drug sales. The good news: a growing body of evidence points to specific, measurable strategies that dramatically improve recruitment speed, patient diversity, and retention.
Use Multiple Recruitment Channels Simultaneously
No single method reaches every eligible patient, and the channels that generate the most initial interest aren’t always the ones that produce the most enrolled, committed participants. A study published in Medical Sciences tracked five recruitment methods side by side and found revealing differences. Social media generated the highest volume of prescreened contacts (102), but only 13 of those people made it to the screening stage. In-person recruitment prescreened fewer people (81) but moved 46 of them all the way through to study completion, a 100% completion rate. Referrals from other patients or providers produced a similar 100% completion rate from a smaller pool.
The takeaway isn’t that one channel is better than another. It’s that layering multiple channels together, including social media for reach, in-person contact for conversion, and referrals for retention, produces the strongest overall enrollment pipeline. Fliers, community events, and provider referrals each contributed meaningfully in this study, and the combination outperformed any single method alone.
Invest in Social Media Advertising
Social media ads are one of the most cost-effective recruitment tools available. One analysis in the Journal of Medical Internet Research found that social media recruitment cost an average of $51.94 per participant. Compare that to traditional channels: television advertising ran $1,094 per participant, printed media about $812, and radio around $636. Even flyers and community events averaged $96.90 per person.
Beyond cost, social media can dramatically accelerate enrollment speed. One UK-based study recruited 55 participants in under a month using Facebook, compared to a national median of 9.2 subjects per site per month through conventional methods. Multiple trials have reported what researchers describe as a “dramatic surge” in enrollment after launching social media campaigns, particularly when ads were targeted by geography, demographics, or health interests. The key is pairing that broad digital reach with a streamlined screening process so high volumes of interest don’t create a bottleneck at the intake stage.
Offer Decentralized or Hybrid Trial Options
Requiring patients to travel to a physical site for every visit is one of the fastest ways to lose potential participants. Decentralized clinical trials, where some or all activities happen remotely through telehealth visits, home nursing, wearable devices, or mail-in sample kits, consistently outperform traditional models on both enrollment speed and retention.
The retention numbers are especially striking. One decentralized trial reported 96% retention, attributed to the ease of participation. Another directly compared a decentralized arm to a conventional arm within the same study and found 89% retention in the decentralized group versus just 60% in the conventional group. Across multiple studies, virtual recruitment was significantly faster than traditional site-based recruitment, and virtual sites consistently showed better retention than their in-person counterparts.
You don’t have to go fully remote. Hybrid models that combine occasional in-person visits with remote data collection and telehealth check-ins capture many of the same benefits while maintaining the clinical oversight that some protocols require.
Reduce Barriers for Referring Physicians
Physician referrals are a high-quality recruitment source, but many doctors simply don’t refer patients to trials. Research on referral barriers reveals why: physicians who viewed the referral process as burdensome, citing time-consuming paperwork, complex protocols, and a lack of staff support, were 72% less likely to refer patients than those who didn’t share those concerns. Additional barriers included fear of losing control over patient care, loss of personal income during the referral process, and difficulty understanding complex trial protocols.
Several practical fixes can increase referral rates. A centralized, user-friendly registry of open trials helps physicians quickly identify relevant studies without sifting through fragmented databases. Involving referring physicians as part of the trial team, with two-way communication about their patients’ progress, addresses the concern about losing control of care. Communication skills training for trial staff has been shown to improve how trials are presented to both physicians and patients, increasing the number of patients offered enrollment. For practices serving diverse populations, multilingual educational materials and bilingual recruitment staff remove a significant communication barrier that otherwise filters out eligible patients.
Build Community Trust Before You Recruit
For underrepresented populations, distrust of medical research is a well-documented barrier that no amount of advertising can overcome on its own. A narrative review of community engagement strategies across rural and underserved populations found that the most frequently used and effective approaches involved three elements: embedding community personnel in the recruitment process (used in 46 studies), establishing feedback loops so community members could shape the research (22 studies), and customizing recruitment materials to reflect the specific culture, language, and concerns of each community (17 studies).
Utilizing local spaces and events, such as community centers, barbershops, churches, and health fairs, appeared in 15 studies and helped researchers reach people who would never encounter a trial through traditional clinical channels. Remuneration for both participants and community liaisons was also common, appearing in 14 studies. The documented outcomes of these strategies included improved recruitment (19 studies), increased trust (8 studies), better retention (7 studies), and successful enrollment of hard-to-reach populations (5 studies).
One notable finding: faith-based organizations, often cited as a recruitment channel, were flagged in at least one study as ineffective. Community engagement works best when it’s genuinely collaborative, not when it treats community institutions as passive distribution channels for flyers.
Cover the Real Costs of Participation
Eligible patients frequently decline or drop out of trials because participation costs them money. Travel expenses, parking fees, lost wages from time off work, and childcare during study visits all create financial friction that disproportionately affects lower-income participants. Research on reimbursement perceptions found that participants were explicit: even women who were genuinely interested in research said they would not undergo procedures, take time off work, or adhere to demanding study schedules without reasonable financial compensation.
Reimbursement that reflects the actual inconvenience of participation improves both enrollment and long-term compliance with trial requirements. Studies among harder-to-retain populations have shown that higher-magnitude payments in cash effectively improved retention for longer-term follow-up without creating perceptions of coercion among participants. Covering transportation, offering stipends for time, and providing flexible scheduling options all reduce the practical burden that keeps willing patients from saying yes.
Use AI to Match Patients to Trials
Manual screening is slow and inconsistent, which partly explains why so many sites fail to meet enrollment targets. AI-powered matching platforms are beginning to change this. One system called DocTr, evaluated across nearly 25,000 clinicians and over 5,200 trials, achieved 58% higher match accuracy than leading baseline methods. It also incorporated fairness optimization, increasing racial and ethnic diversity metrics by 9% and 25% respectively compared to ground-truth matching, and reduced competition between trials recruiting from the same patient pools to near zero.
These tools work by analyzing electronic health records, physician specialty profiles, and trial eligibility criteria simultaneously, identifying matches that human coordinators would miss or take weeks to find. The practical effect is faster identification of eligible patients, more appropriate site selection, and a broader, more representative participant pool from the start.
Plan for Diversity From the Beginning
The FDA now requires diversity action plans for certain clinical studies, mandated under the Food and Drug Omnibus Reform Act (FDORA). These plans must describe how sponsors intend to enroll participants from underrepresented populations, and the FDA has issued guidance on the format, content, and submission process. Sponsors can request waivers, but the default expectation is that diversity planning is built into trial design from the outset rather than treated as an afterthought.
Beyond regulatory compliance, diverse enrollment improves the scientific validity of trial results. Drugs that are tested predominantly in one demographic group may behave differently in others. Building diversity into your recruitment strategy early, through community partnerships, multilingual materials, decentralized access options, and representative site selection, addresses both the regulatory requirement and the scientific need simultaneously.